Luye Pharma Group Ltd. (OTCMKTS:LYPHF – Get Free Report) was the recipient of a large increase in short interest in May. As of May 15th, there was short interest totaling 286,500 shares, an increase of 139.7% from the April 30th total of 119,500 shares. Based on an average daily volume of 18 shares, the days-to-cover ratio is currently 15,916.7 days.
Luye Pharma Group Stock Performance
OTCMKTS LYPHF remained flat at $0.33 on Monday. The stock has a 50 day moving average price of $0.35 and a 200 day moving average price of $0.37. Luye Pharma Group has a 1-year low of $0.30 and a 1-year high of $0.33.
About Luye Pharma Group
Luye Pharma Group Ltd. is a China-based pharmaceutical company headquartered in Yantai, Shandong Province. Established in 1994, the company specializes in the research, development, manufacturing and marketing of a broad portfolio of medicaments and health-care products. Luye Pharma structures its operations across three main segments: innovative drugs, generic drugs and over-the-counter (OTC) health and wellness products. Through in-house R&D and strategic collaborations, the company aims to address unmet medical needs in both domestic and international markets.
The company’s product offerings encompass key therapeutic areas such as oncology, cardiovascular disease, gastroenterology and respiratory illnesses.
Further Reading
- Five stocks we like better than Luye Pharma Group
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for Luye Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luye Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
